No Data
Boji Medical Technology (300404.SZ) shareholders Zhao Lingli and Fermi No. 13 completed shareholding, totaling a 1.5% reduction in shares.
boji medical technology (300404.SZ) announced that the company has received the unanimous consent of the controlling shareholder and actual controller, Mr. Wang Tingchun...
boji medical technology (300404.SZ): Currently, the company has no research projects on anti-aging drugs.
According to Gelonhui on October 31, boji medical technology (300404.SZ) stated on the investor interaction platform that the company currently has no research projects on anti-aging drugs.
Broge Pharmaceuticals: Report for the third quarter of 2024
Boji Medical Technology (300404.SZ) released its performance for the first three quarters, with a net income of 43.2778 million yuan, an 87.98% year-on-year increase.
Boji Medical Technology (300404.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching...
Boji Medical Technology (300404.SZ): The net income for the first three quarters was 43.2778 million yuan, a year-on-year increase of 87.98%.
Boji Medical Technology (stock code: 300404.SZ) announced its third quarter report for the year 2024 on October 25th. The company achieved a revenue of 0.556 billion yuan in the first three quarters, an increase of 55.01% year-on-year; the net income attributable to shareholders of the listed company was 43.2778 million yuan, an increase of 87.98% year-on-year; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.8898 million yuan, an increase of 155.65% year-on-year; and the basic earnings per share was 0.1133 yuan.
Boji Medical Technology Unit Gets Patent for Joint Pain Treatment
Market Cool On Boji Medical Technology Co., Ltd.'s (SZSE:300404) Revenues Pushing Shares 25% LowerNo Data
No Data
